Scott Nelson Live

In this episode, we sat down with Ziv Peremen, CEO of X-trodes.

After completing his PhD in neurocognitive science with a specializaton in understanding consciousness, Ziv Peremen has spent the past 12 years focused on the intersection of data and physiology. Together with Professor Yael Hanein, an expert in the field of human-machine interface learning and inventor of innovative sensor technology, they founded X-trodes.

In this interview, Ziv discusses his wireless wearable sleep diagnostic technology, commercializing a product before FDA clearance, and how to build the right company infrastructure from the start.

In this episode, we sat down with Jim Pursley, President of Hinge Health.

Jim has spent the last decade tackling some of the biggest problems in healthcare. He was part of the founding executive team as the Chief Commercial Officer of Livongo Health, and took the company public, culminating in an $18.5B acquisition by Teladoc Health. Since March 2021,  Jim has been Hinge Health's President. The company is ranked #2 on Crunchbase's Diversity Spotlight Report.

In this interview, Jim discusses finding the right market, being your own biggest critic, and marrying clinical improvements with cost savings.

In this episode, I sat down with myself. Well, sort of. 

This unique episode of Medsider flips the script, putting myself in the interviewee seat alongside my good friend, and temporary host, Brett Johnston. We discussed where founders should focus early on, guidance for taking the leap from your corporate position, and how to know which opportunities to pursue.

If you’re new to this show, here’s a little more about me: 

I spent the last two decades in the medtech space, starting in medical device sales roles that ultimately led to startup leadership positions. During that time, I followed my curiosity through several career transitions while engaging in side projects along the way. I'm the founder of Medsider, Joovv, Crossfire Medical, and FastWave Medical. The latter two are spinouts from Big Sky Biomedical, a medtech accelerator that I also started with several other serial entrepreneurs.

In this episode, we sat down with Jennifer Ernst, CEO of Tivic Health.

Jennifer came to the medtech space after more than 20 years in the computing and electronics industries, serving in high-profile roles at Xerox PARC and Thin Film Electronics. In 2016, Jennifer founded direct-to-consumer medtech company Tivic Health and helped lead the development and commercialization of the company’s flagship device ClearUP.

In this interview, Jennifer shares how consumers can play a key role in boosting support and evidence for over-the-counter medical devices, and why she thinks direct-to-consumer business models will transform the medtech space.

In this episode, we sat down with Dan Clark, President of Linear Health Sciences.

 Dan Clark started his career in the private sector at Parker Hannifin, a Fortune 200 organization that he calls “the largest company you’ve never heard of.” After experiencing the medtech innovation cycle many times over, he was eager to innovate himself. In 2015, Dan teamed up with Dr. Ryan Dennis to start Linear Health Sciences, a medtech company that created the Orchid, a device designed to mitigate unwanted or accidental IV dislodgement.

In this interview, Dan explains when and how Linear raised capital, how it has navigated complex regulatory pathways, and why you need to be your own worst enemy as an innovator.

In this episode, we sat down with Heather Underwood, CEO of EvoEndo.

Heather is a medical device and health technology entrepreneur with a highly interdisciplinary background at the intersection of computer science, global health, human-centered design, education, and international development.

In this interview, Heather elaborates on her unique approach to innovation in the medtech arena, how fundraising isn’t one-size-fits-all, and why regulatory clearance isn’t the end of the road.

In this episode, we sat down with Yoav Kimchy, Founder and CTO of Check-Cap.

Yoav has more than 20 years of experience in the development and management of innovative medical device companies. In 2005, he founded Check-Cap, a clinical-stage medical diagnostics company that aims to change the colorectal cancer (CRC) screening landscape with its C-Scan ingestible capsule, tracing, and imaging system. 

In this discussion, Yoav shares how early feedback from regulators can help streamline your development efforts, why you should shift your team as the company grows, and the importance of knowing when to lead and when to follow.

In this episode, we sat down with Bryce Klontz, President and CEO of New View Surgical.

With over 20 years of experience working in the surgical device space from Canada to Singapore, Bryce brings a tactical advantage to his role as the CEO of New View Surgical. 

Under his leadership, New View Surgical has closed a successful Series B with a cumulative total of $14.5 million in investments and secured 510(k) clearance along the way. He previously worked as the VP of Commercial Strategy for Emerging Markets at Covidien in addition to leadership roles at several other startups.

In this discussion, Bryce shares insights from his decades of experience in the surgical devices space, from building relationships of trust with regulators and investors to working closely with practitioners to perfect product-market fit. 

In this episode, we sat down with Eugene Malinskiy, CEO and Co-founder of Lazurite.

Eugene is a serial entrepreneur with expertise in the IT and medical fields. He also has hands-on experience as a medic and has worked in operating rooms throughout the country. He founded Lazurite, an innovative healthcare company focused on cutting-edge surgical and lighting technologies, in 2015. That same year, Eugene was selected as one of Forbes 30 Under 30 recipients in the manufacturing sector.

In this discussion, Eugene shares how planning out every step of ArthroFree’s regulatory strategy helped streamline the FDA clearance process, the importance of preparing for failure and being ready to solve problems, and why entrepreneurs should seek out input from investors at every step of the process. 

In this episode, we sat down with Cody Simmons, CEO of DermaSensor.

Cody spent four years learning about business strategy and analytics at biotechnology giant Genentech before becoming CEO of DermaSensor in 2016, where he leads development and commercialization efforts for the company’s novel skin cancer detection tool. In 2018, he was included on the Forbes 30 Under 30 list in healthcare.

In this discussion, Cody shares why he thinks companies need to focus on regulatory and reimbursement alignment from the very beginning, the importance of finding ally investors, and how to build trust with potential partners in your network.